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Abstract 26 
The multitude of biomolecular and regulatory factors involved in staphylococcal 27 
adhesion and biofilm formation owes much to their ability to colonise surface and 28 
become the preferential bacterial phenotype.  Judging on total number, biomass and 29 
variety of environments colonised, bacteria can be categorised as the most successful 30 
life form on earth.  This is due to the ability of bacteria and other microorganisms to 31 
respond phenotypically via biomolecular processes to the stresses of their surrounding 32 
environment.  This review focuses on the specific pathways involved in the adhesion 33 
of the Gram-positive bacteria Staphylococcus epidermidis and Staphylococcus aureus 34 
with reference to the role of specific cell surface adhesins, the ica operon, 35 
accumulation associated proteins and quorum sensing systems and their significance 36 
in medical device related infection. 37 
 38 
Main text 39 
Introduction 40 
Microorganisms have been implicated in a variety of problems within the food, oil, 41 
paper and medical industries [1].  The ability of microorganisms to attach to surfaces 42 
provides an evolutionary advantage allowing maturation, increased survival and 43 
symbiotic relationships to be established within the biofilm environment.  44 
Upregulation of specific genes allow and the associated molecular processes enable 45 
planktonic free-flowing cells to attach to surfaces, aggregate and form a hydrated 46 
extracellular polymeric matrix which is phenotypically advantageous for survival [2].  47 
Gram-positive microorganisms such as Staphylococcus epidermidis and 48 
Staphylococcus aureus are present on the skin of humans as part of their resident 49 
microflora [3].  In healthy individual they confer a mutualistic benefit with their host 50 
by preventing colonisation of the skin surface by transient pathogenic 51 
microorganisms.  However in circumstances were the host’s immunity becomes 52 
impaired, such as trauma associated with medical device implantation, resident 53 
bacteria can become opportunistic attaching to the biomaterial surface and forming 54 
resistant biofilms.  The purpose of this review is to explore the differences and 55 
similarities in the molecular processes involved in Gram-positive biofilm formation, 56 
with particular relevance to staphylococci.  Understanding these processes may 57 
provide a means whereby the biofilm’s properties of increased resistance to shear 58 
stress, superior utilisation of nutrients, energy and increased antimicrobial resistance 59 
may be overcome. 60 
 61 
Processes involved in Gram-positive biofilm formation: Staphylococcus 62 
epidermidis and Staphylococcus aureus 63 
Staphylococcus epidermidis is the most prevalent biofilm forming coagulase negative 64 
staphylococci [4].  Numerous research has been conducted to characterize the various 65 
stages, genes and pathways involved in biofilm formation, the majority of these 66 
factors are outlined in Figure 1.    67 
 68 
Adhesion in staphylococci 69 
Cell surface hydrophobicity and cell surface adhesins 70 
The primary or nonspecific adhesion of staphylococci is due mainly to the cell and 71 
cell surface hydrophobicity [5].  In terms of adherence to smooth, abiotic surfaces, 72 
such as those present on many biomaterial surfaces, the galactose and glucosamine 73 
rich capsular polysaccharide-adhesin is reported to have an important role [6].  74 
Capsular polysaccharide-adhesin is composed of a high molecular weight (28 kDa) 75 
polymer of β-1,6-linked N-acetylglucosamine residues with O-linked phosphate, 76 
succinate and acetate substituents on the amino groups.  These groupings confer 77 
further hydrophobic character to the Staphylococcus bacterial capsule [7].  Another 78 
role of capsular polysaccharide-adhesin in staphylococci is to offer protection against 79 
the host’s immune response, for example complement-mediated antibody-independent 80 
opsonic killing, through the physical formation of the slimy bacterial capsule that acts 81 
as a barrier to phagocytosis [8].  The glucose rich extracellular slime associated 82 
antigen was discovered by Christensen et al [9].  Antigenically different to capsular 83 
polysaccharide-adhesin, slime associated antigen is also heat and protease stable.  It 84 
was observed, through characterisation of capsular polysaccharide-adhesin positive 85 
and slime associated antigen positive and negative strains, that capsular 86 
polysaccharide-adhesin was responsible for the process of surface attachment whereas 87 
slime associated antigen is linked to accumulation and biofilm maturation at the 88 
surface.  Research has shown slime associated antigen to be chemically identical to 89 
polysaccharide intercellular adhesin [10].  Both polysaccharide intercellular adhesin 90 
and capsular polysaccharide-adhesin share a β-1,6-linked-polyglucosamine backbone, 91 
with differences occurring in the primary substituent present on the amino groups.  92 
They are both synthesized from the proteins encoded by the ica operon [11].  93 
 94 
The discovery of a Tn917 insertion mutant of Staphylococcus epidermidis by 95 
Heilmann et al confirmed the importance of hydrophobicity, particularly in relation to 96 
plastics [12].  They observed that this mutant was significantly less hydrophobic than 97 
a wild type strain (O-47) and thus was unable to adhere to a polystyrene surface.  98 
Another Tn917 mutant was also lacking in four important cell surface adhesins, 99 
required for secondary adhesion, but the genetic restoration of one of these adhesins 100 
(of molecular mass 60 kDa) fully restored adherence capabilities and showed the 101 
importance of surface bound adhesins in Staphylococcus adhesion.  The secondary 102 
attachment of Staphylococcus epidermidis is improved by the presence of the cell 103 
adhesion autolysin E, which binds to plasma proteins such as vitronectin present in 104 
the conditioning layer formed on implanted biomaterials [13].  The 60-kDa adhesion 105 
analysed by Heilmann et al was shown to be a proteolytic fragment of autolysin E 106 
[14].  Heilmann et al are also responsible for the characterisation of a novel autolysin-107 
adhesin in Staphylococcus epidermidis [15].  This surface bound novel autolysin-108 
adhesin was shown to be 35kDa in molecular mass and possess bacteriolytic 109 
properties, with saturable dose dependent adhesion to fibronectin, fibrinogen and 110 
vitronectin also shown in vitro.  Biofilm formation in Staphylococcus epidermidis is 111 
not reliant on autolysin and autolysin-adhesin expression alone and it is still unknown 112 
whether autolysin E mediates attachment directly or helps to expose alternative 113 
adhesins [16].   114 
 115 
There are several surface bound proteins in Staphylococcus epidermidis that are 116 
responsible for binding specifically to collagen, vitronectin, fibronectin and 117 
fibrinogen and other proteins present in the extracellular matrix.  Included in these 118 
proteins together with autolysin and autolysin-adhesin are; the collagen binding 119 
extracellular lipase GehD [17]; the large (1 MDa) fibronectin binding protein Embp 120 
[18] and the fibrinogen binding proteins and SdrG [19].  Both fibrinogen binding 121 
protein and SdrG are members of the same staphylococcal surface protein gene 122 
family, sharing similar dipeptide serine-aspartate repeats, sortase cleavage sites, 123 
hydrophobic and cationic domains [20].  The gene encoding for fibrinogen binding 124 
protein (fbe) has been isolated in the majority of Staphylococcus epidermidis strains, 125 
with an incidence of 95% in clinical isolates [21].  Fibrinogen binding protein is the 126 
only true microbial surface components recognizing adhesive matrix molecule 127 
(MSCRAMM) found in Staphylococcus epidermidis and although it is present in 128 
Staphylococcus aureus it also has similar structural and functional properties to 129 
clumping factor (ClfA) found in some strains of Staphylococcus aureus [22].  130 
Clumping factor A (ClfA) is a cell wall-associated adhesin that mediates binding to 131 
fibrinogen and platelets, and although staphylococci share many adhesive properties 132 
and mechanisms it has only been isolated in Staphylococcus aureus [23].  Similarly 133 
the cell-wall protein clumping factor B (ClfB) of Staphylococcus aureus aids 134 
adhesion and colonisation to squamous epithelial cells present in nasal passages [24].  135 
MSCRAMMs are more prevalent in Staphylococcus aureus, including clumping 136 
factors A and B (ClfA and ClfB), collagen binding protein and fibronectin binding 137 
factors A and B [25].  Binding to fibrinogen by these isolates varies however, leading 138 
to the hypothesis that fibrinogen binding protein and other surface adhesins are 139 
expressed to different degrees when comparing multiple isolates.  Factors such as 140 
protease activity, sortase cleavage of the Leu-Pro-Xaa-Thr-Gly (LPXTG) amino acid 141 
sequence motif, insufficient length of Shine-Dalgarno repeat region and capsular 142 
formation may determine the extent to which adhesins are exposed [26].    143 
 144 
The action of sortase, namely sortase A, in staphylococci and other Gram-positives is 145 
of importance in the covalent anchoring of surface adhesins to peptidoglycan in the 146 
cell wall allowing them to be readily available for attachment [27].  MSCRAMMs 147 
such as fibrinogen binding protein are composed of three distinct regions namely; a 148 
hydrophobic portion; a charged tail and most importantly a LPXTG motif, where X 149 
represents any amino acid [28].  By cleavage of this motif between the threonine and 150 
glycine residues an acyl-enzyme intermediate is formed within the sortase active site, 151 
with nucleophilic attack of the amino groups present in the cell wall crosslinks 152 
allowing binding of MSCRAMMs to peptidoglycan in the cell wall [29].   153 
 154 
The role of teichoic acids 155 
Cell wall teichoic acids are the highest source of polyanionic charge on the 156 
staphylococcal bacterial cell envelope [30].  Research has also shown that increased 157 
cationic charge provided by incorporation of D-alanine into teichoic acids, an 158 
important component of the staphylococcal extracellular matrix, is a determinant in 159 
the successful attachment of staphylococci to biomaterials [31][32][33].  The 160 
production of teichoic acids is controlled by the dlt gene operon; it is this gene 161 
sequence that is responsible for D-alanine incorporation [30].  Gross et al showed 162 
gene mutants of dlt, namely dltA, that did not incorporate D-alanine were teichoic 163 
acid negative and failed to adhere to glass and polystyrene [33].  They concluded that 164 
despite other adherence factors being present, including the ica operon and 165 
polysaccharide intercellular adhesin production, the electrostatic repulsive forces 166 
induced by increased cell negativity of staphylococci lead to prevention of bacterial 167 
adhesion to polystyrene and glass.  Although these results may show some correlation 168 
between cell surface charge and electrostatic forces in biofilm formation, there is no 169 
conclusive evidence for the activity of dltA staphylococcal mutants in other polymers 170 
such as Teflon.  Research performed by Vergara-Irigaray and colleagues showed cell 171 
wall absent teichoic acid mutants to have similar levels of poly-N-acetylglucosamine 172 
production; a higher degree of cell aggregation but reduced capacity to form biofilms 173 
compared with wild type [34].  Attachment with Biofilm formation itself has been 174 
shown to be restored with the addition of magnesium but not calcium ions, showing 175 
that the balance of charge at the surface of Gram-positive bacteria is important in 176 
determining adhesion and ultimately biofilm formation, with the cationic charge of 177 
magnesium ions acting as a direct replacement for that of D-alanine [31][35].  Mutant 178 
dltA staphylococci have also been shown to be more sensitive to vancomycin and host 179 
defence peptides [36]. 180 
 181 
Accumulation and the ica operon in staphylococci 182 
The accumulation of cellular aggregates at the surface of the biomaterial is a key stage 183 
in the adhesion of biofilm forming microorganisms in medical device related 184 
infection.  Approximately 85% of Staphylococcus epidermidis strains from infective 185 
blood cultures have been shown to possess the ica gene cluster [37].  Polysaccharide 186 
intercellular adhesin is localized to the cell surface and is the key component for the 187 
intercellular adhesion of Staphylococcus epidermidis.  Together with capsular 188 
polysaccharide-adhesin, polysaccharide intercellular adhesin is a product of the ica 189 
gene operon, the most understood biofilm mediating pathway in staphylococci [38].  190 
Sharing the same linear β-1,6-linked-polyglucosamine backbone as capsular 191 
polysaccharide-adhesin, polysaccharide intercellular adhesin can exist as one of two 192 
polysaccharides termed polysaccharide intercellular adhesin I or polysaccharide 193 
intercellular adhesin II with an average chain length of 130 residues [39].  Deacylated 194 
N-acetylglucosamine accounts for 15-20% of polysaccharide intercellular adhesin and 195 
is essential for its functional properties including the ability to colonize, form biofilms 196 
and resist phagocytosis by neutrophils and antibacterial peptides [40].  The ica gene 197 
operon codes for the proteins and enzymes responsible for polysaccharide 198 
intercellular adhesin production.   199 
 200 
This ica gene cluster can be further differentiated to the icaA, icaD, icaB and icaC 201 
loci each responsible for relevant pathogenic and virulent factors involved in 202 
polysaccharide intercellular adhesin synthesis [40][38][41].  The transcription of the 203 
icaADBC gene operon is negatively regulated by an adjacent five nucleotide base 204 
icaR gene sequence, that itself codes for a transcriptional regulator that binds to the 205 
icaADBC promoter [42][35].  Evidence for the role of icaR has been verified through 206 
deletion of the icaR gene corresponding to increased polysaccharide intercellular 207 
adhesin production [43].  The proteins transcribed, icaA, icaD, icaB and icaC have 208 
separate but correlating functions in polysaccharide intercellular adhesin synthesis 209 
(Figure 2).  IcaA is a transmembrane protein similar to N-acetyl-210 
glucosaminyltransferases and works in tandem with icaD, also positioned on the 211 
cytoplasmic membrane, to form N-acetyl-glucosamine oligomers with UDP-N-212 
acetylglucosamine as a substrate [35].  When both proteins are transcribed oligomers 213 
may form to a maximum of 20 residues in length.  The presence of the integral 214 
membrane protein icaC increases both the length of N-acetyl-glucosamine oligomers 215 
and allows for the translocation of the polysaccharide through the cytoplasmic 216 
membrane to the cell surface [41].  The expression of icaA, icaD and icaC are a 217 
necessary requirement for the production of polysaccharide intercellular adhesin, with 218 
the deacetylase-like icaB conferring significant functional virulence and cationic 219 
charge by deacetylation of the poly-N-acetylglucosamine sequence [41][40].  It is 220 
likely that an uncharged fully acetylated N-acetylglucosamine primary product is 221 
produced, with a second icaB protein mediated deacetylation step leading to 222 
positively charged N-glucosamine oligomers.   223 
 224 
This hypothesis has developed from the observation that in in vitro synthesis 225 
pathways no virulence dependent deacetylated residues have been isolated.  There has 226 
been much debate as to the location of icaB as many papers hypothesize it to be 227 
secreted into the surrounding medium acting as a peptide signal molecule [38][35].  228 
More recently Vuong et al obtained results to indicate that icaB interacts with the 229 
staphylococcal cell surface through non-covalent means, with its location likely to be 230 
in the cell surface matrix [40].  The role of the ica gene operon in regulating biofilm 231 
formation, adhesion and virulence has been proven by the introduction of the 232 
icaRADBC sequence into strains of Staphylococcus epidermidis that were previously 233 
icaADBC negative and biofilm negative [13].  The presence of the icaRADBC gene 234 
cluster allows the production of polysaccharide intercellular adhesin leading to 235 
increased biofilm formation when sufficient IcaB protein allows for 236 
deacetylation[44][40].   237 
 238 
Regulation of icaR transcription in Staphylococcus epidermidis is controlled by the 239 
alternative sigma factor σB which itself is positively regulated by the protein RsbU via 240 
activation of environmental stresses for example heat, acid, salt or ethanol shock [45].  241 
Also included in this regulatory cascade are; the anti-sigma factor RsbW, the anti-anti 242 
sigma factor RsbV, with RsbU acting as a RsbV-specific phosphatase as outlined in 243 
Figure 3.  This mechanism is true for Staphylococcus epidermidis but not 244 
Staphylococcus aureus [46].  The production of an uncharacterized intermediate 245 
protein molecule, σB indirectly represses the transcription of the icaR operon and its 246 
expression is especially important in the stability of Staphylococcus epidermidis 247 
biofilm under environmental stresses, such as lack of nutrients [47].  Knobloch et al 248 
proved alterations in the gene responsible for RsbU transcription (RsbU), via the use 249 
of a Tn917 insertion mutant, results in a Staphylococcus epidermidis strain that cannot 250 
express σB.  It was observed in this class III mutant, labelled M15, that the icaADBC 251 
operon was not transcribed suggesting σB expression is essential for icaADBC activity 252 
in Staphylococcus epidermidis [45].  Both ethanol and high osmolarity (both 253 
environmental stresses) have been shown to be inducers of σB.  Knobloch et al also 254 
observed that the presence of ethanol could result in the restoration of biofilm 255 
formation in mutant M15 but the presence of sodium chloride (NaCl) salt would not 256 
restore biofilm formation.  However it has also been proposed by Conlon et al 257 
that icaADBC operon activation by ethanol is only icaR dependent whereas for NaCl 258 
to activate icaADBC expression both icaR and σB activity are required [48].  With 259 
these theories in mind two regulatory pathways could exist in Staphylococcus 260 
epidermidis to control biofilm formation with the ethanol mediated pathway acting 261 
independently of σB [49].  This alternative ethanol induced pathway could involve 262 
activation of σB by RsbU substitutes or the formation of polysaccharide intercellular 263 
adhesin by a completely different pathway independent of σB, as Conlon et al suggest 264 
[48].  This mechanism may follow that of other biofilm forming staphylococcal 265 
species [50].  It is still unclear how responsible σB is for the control of icaADBC 266 
operon transcription as no identifiable σB binding site has been identified close to 267 
icaADBC [51].  One explanation of σB control of the icaADBC is through the presence 268 
of genes that code for staphylococcal accessory regulator, a global regulator that is 269 
commonly associated with Staphylococcus aureus biofilm development, where σB is 270 
only essential in a minority of strains [52][53][46].   271 
 272 
SarA is an essential element in the synthesis of polysaccharide intercellular adhesin 273 
and biofilm development in Staphylococcus aureus through the icaADBC operon with 274 
environmental signals such as ethanol, salt stress and iron limitation important [54].  275 
For Staphylococcus aureus in particular, the staphylococcal accessory regulator 276 
protein A has been shown to be positively regulated by σB [51].  Although further 277 
research by Valle et al has shown σB  negative Staphylococcus aureus to still have 278 
biofilm forming potential suggesting the production of staphylococcal accessory 279 
regulator has still to be characterized fully [46].  84% of the staphylococcal accessory 280 
regulator protein present in Staphylococcus epidermidis corresponds to that of 281 
Staphylococcus aureus, however the regulation of staphylococcal accessory regulator 282 
varies due to the differing organisation of staphylococcal accessory regulator 283 
promoters at a nucleotide level [55].  Staphylococcal accessory regulator binds to and 284 
positively regulates the icaADBC operon with high affinity through an icaR 285 
independent mechanism [56].  The staphylococcal accessory regulator gene has been 286 
implicated in the agr quorum sensing system of staphylococci but mediates biofilm 287 
formation via an agr independent pathway [57].  Purine biosynthesis is also 288 
associated with ica expression and biofilm formation in Gram-positive 289 
microorganisms and although no direct binding site for purines or preceding genes 290 
that code for purines exist on the icaADBC operon, purines may play an indirect role 291 
in icaADBC regulation [58]. 292 
 293 
The accumulation associated proteins in staphylococci 294 
The importance of biofilm formation for the survival of Staphylococcus epidermidis 295 
and staphylococci generally means that the ica operon itself is not a necessity for 296 
biofilm formation.  A number of ica independent mechanisms exist as shown by 297 
strains of Staphylococcus epidermidis lacking icaADBC but still forming biofilms 298 
[37][59][60].  Accumulation associated protein has been shown to be involved in the 299 
accumulation of Staphylococcus epidermidis independently of polysaccharide 300 
intercellular adhesin.  Past research had deemed accumulation associated protein to be 301 
a cell wall receptor for polysaccharide intercellular adhesin [61].  In Staphylococcus 302 
aureus the surface protein G is homologous to the accumulation associated protein of 303 
Staphylococcus epidermidis, however although it has been linked to intranasal 304 
adhesion of Staphylococcus aureus its in vivo activity is less characterized than 305 
accumulation associated protein [62].  Rohde et al proved that limited proteolysis of 306 
accumulation associated protein by endogenous serine and metalloproteases and 307 
exogenous trypsin, elastase and cathepsin G induced biofilm formation [63].  308 
Proteolytic processing of accumulation associated protein leads to the removal of the 309 
N-terminal domain resulting in the exposure of N-acetylglucosamine binding 310 
domains, also termed G5 domains due to the prominence of glycine residues [64].  311 
Protease production itself is controlled via quorum sensing pathways such as the agr 312 
and sarA in staphylococci, thus biofilm formation via accumulation associated protein 313 
is linked to virulence [65].   314 
 315 
Quorum sensing in staphylococci:  316 
I. The accessory gene regulator system (agr) 317 
Symbiosis, antibiotic production, biofilm formation and virulence are defined by two 318 
quorum sensing systems in staphylococci.  These are the accessory gene regulator 319 
system (agr) and the luxS system [66][67][68].  The accessory gene regulator system 320 
(agr) consists of two units RNA-II and RNA-III whose transcription is dependent on 321 
the activation of their respective P2 and P3 agr promoters [69].  RNA-II consists of 322 
four genes agrB, agrD, agrC and agrA [70].  The autoinducing peptide backbone is 323 
synthesized via transcription of the agrD gene.  The product of agrB transcription is a 324 
protease that cleavages portions of the agrD product to form a thiolactone ring 325 
structure (lactone ring in one case) of approximately 8 amino acids in length, 326 
otherwise known as autoinducing peptide [71].  AgrC is the sensory kinase of the agr 327 
quorum sensing system with the binding of a threshold concentration of autoinducing 328 
peptide to this transmembrane protein resulting in activation of AgrA via 329 
phosphorylation or dephosphorylation (Figure 4).  This autoinductive pathway results 330 
in RNA-II and RNA-III (the effector molecule of the agr system) transcription via the 331 
activation of the promoters P2 and P3 by activated AgrA aided by SarA [58].   332 
 333 
The activation of the agr system correlates to the mid to end point of exponential 334 
growth and entry into the stationary phase of growth with the down regulation of cell 335 
surface protein related genes but an upregulation in virulence factors [72].  This leads 336 
to the production of the regulatory RNA-III molecule that initiates the transcription of 337 
genes coding for a variety of virulent proteins (toxins) including enterotoxin B also 338 
known as Staphylococcus aureus exoprotein expression regulator and Staphylococcus 339 
serine proteases and Staphylococcus proteases (spr) and controls the downregulation 340 
of genes encoding cell surface proteins and adhesion, for example Staphylococcus 341 
protein A and fibronectin-binding [73][74].  The overall picture is not as simplistic 342 
however, as research conducted by Vuong et al has shown the genes coding the 343 
adhesin autolysin E (altE) are upregulated by agr quorum sensing pathways in 344 
Staphylococcus epidermidis and sarA appears upregulated similarly in Staphylococcus 345 
aureus thereby increasing biofilm formation [72].  However as stated previously 346 
staphylococcal accessory regulator gene has been implicated in the agr quorum 347 
sensing system of staphylococci but mediates biofilm formation via an agr 348 
independent pathway [57].  The possibility still remains that agr may mediate 349 
adhesion in Staphylococcus epidermidis strains particularly in reference to 350 
biomaterials [13].  As intercellular adhesion in staphylococci is influenced by 351 
polysaccharide intercellular adhesin production, it has been shown that the luxS 352 
quorum sensing system, not agr, has a role in down-regulating this process [67].   353 
 354 
The importance of agr to the biofilm process is greatest at the detachment phase of 355 
growth [75][76].  Wild type staphylococci that utilize agr have biofilms that are less 356 
thick than agr negative mutants due to an ability to detach from the matured biofilm, 357 
rather than decreased microbial growth [77].  Detachment in both Staphylococcus 358 
epidermidis and Staphylococcus aureus occurs due to the production of short 359 
amphipathic peptides known as phenol-soluble modulins, such as δ-toxin, encoded by 360 
regulatory RNA-III molecule and mediated by the agr regulatory system.  These 361 
peptides themselves have no autoinducing or regulatory affect on the agr system [76]. 362 
 363 
The ability of microorganisms to coordinate a range of actions and phenotypic traits, 364 
via a process such as quorum sensing, shows that this mechanisms itself may be a 365 
specific target in reducing biofilm formation and virulence associated with medical 366 
device related pathogens [78][79].  Research by Balaban et al have shown that RNA-367 
III inhibiting peptide has significant activity in preventing Staphylococcus 368 
epidermidis and Staphylococcus aureus biofilm formation using an in vivo rat Dacron 369 
graft model [80].  RNA-III inhibiting peptide targets RNA-III activating protein, to 370 
prevent the phosphorylation of the protein target of RNA-III activating protein.  The 371 
release of RNA-III activating protein and phosphorylation of the protein target of 372 
RNA-III activating protein is itself a quorum sensing process leading to the formation 373 
of numerous surface adhesion proteins, together with the autoinducing expression of 374 
the agr operon controlling biofilm formation in staphylococci (Figures 5 and 6) [81].  375 
RNA-III inhibiting peptide itself is a heptapeptide of structure of amide form, 376 
YSPWTYNF-NH2, is non-pathogenic as it inhibits cell to cell communication via 377 
competing for binding sites on the protein target of RNA-III activating protein but it is 378 
not bactericidal [82].  379 
 380 
II. Quorum sensing in staphylococci: the luxS system 381 
Whereas the agr system has no effect on the icaADBC gene operon and 382 
polysaccharide intercellular adhesin formation the presence of an alternative quorum 383 
sensing luxS has been linked to preventing the production of polysaccharide 384 
intercellular adhesin in staphylococci via downregulation of icaADBC [83].  Present 385 
in both Gram-positive and Gram-negative bacteria the luxS quorum sensing system 386 
results in the formation of autoinducing peptide-II [84][85][86].  LuxS and agr absent 387 
mutants both shared the common properties of forming thicker but less virulent 388 
biofilms than wild type strains of Staphylococcus epidermidis [67].  This research by 389 
Xu et al claimed that thinner biofilm growth in luxS positive strains was due to a 390 
downregulation in the icaADBC operon rather than cellular metabolic processes as 391 
there were no noticeable differences in the growth patterns of luxS negative and 392 
positive strains.  This contrast to the theory put forward by Vendeville et al who 393 
observed that luxS is involved in the activated methyl cycle and thus may alter the 394 
metabolism and biofilm formation of bacteria [87].   395 
 396 
The synthesis of autoinducer-II occurs in three enzyme enzymatic steps.  The 397 
substrate molecule is S-adenosylmethionine, a molecule found as a cofactor for many 398 
DNA- and RNA-linked processes including protein synthesis.  The presence of 399 
methyltransferases results in S-adenosylmethionine donating methyl groups to a 400 
variety of substrates in the methyl cycle to form the toxic intermediate S-401 
adenosylhomocysteine.  The nucleosidase enzyme Pfs (5′methylthioadenosine/S-402 
adenosylhomocysteine nucleosidase) mediates the hydrolysis of S-403 
adenosylhomocysteine to S-ribosylhomocysteine via the loss of adenine.  At this stage 404 
the transcription of luxS with the formation of LuxS leads to the catalysis of S-405 
ribosylhomocysteine cleavage to 4,5-dihydroxy 2,3-pentanedione and homocysteine 406 
[88].  The production of 4,5-dihydroxy 2,3-pentanedione to autoinducing peptide-II is 407 
relatively uncharacterized in the literature with Xavier et al stating that 5-dihydroxy 408 
2,3-pentanedione cyclizes to form pro-autoinducer-II, and subsequently boron is 409 
added to form autoinducer-II in Gram-negative Vibrio harveyi.  A similar mechanism 410 
may exist in Gram-positives also (Figure 7) [85]. 411 
 412 
Conclusions 413 
Biofilms are particularly prevalent in marine ecosystems where they constitute more 414 
than 99.9% of bacteria present with these results correlating to the majority of 415 
ecosystems [89].  This suggests a selective evolutionary advantage for biofilm 416 
forming microorganisms over planktonic forms [25].  Infections of medical devices 417 
are a significant problem due to their high impact on patient morbidity, mortality and 418 
monetary expenditure.  Most device related infections are due to contamination of the 419 
device from environmental pathogens, such as staphylococcal skin flora, both before 420 
and during implantation [90].  Biomolecular processes form a viable target by which 421 
treatment strategies may be developed to prevent bacterial adherence and transfer 422 
from planktonic to more resistant biofilm forms.  In Gram-positive bacteria potential 423 
treatment strategies include influencing the agr and luxS quorum sensing systems.  424 
Inhibiting the agr quorum sensing signal has been show to increase attachment and 425 
biofilm production in both Staphylococcus epidermidis and Staphylococcus aureus 426 
[72][91].  This contrasts to what is seen with quorum sensing systems in Gram 427 
negative microorganisms such as Pseudomonas aeruginosa [92], further evidence that 428 
increased study is required in this area to positively affect clinical outcomes.  For 429 
staphylococcal biofilms, future work will be required to focus on the specific role and 430 
action of teichoic acids, present at high density throughout the biofilm matrix, cell 431 
surface adhesins and MSCRAMMs as promising drug targets for vaccine 432 
development.  For example Stranger-Jones et al, showed a vaccine containing the 433 
MSCRAMMs IsdA, IsdB, SdrD, and SdrE were identified as protective in a murine 434 
model of Staphylococcus aureus abscess formation [93].  Inhibition of sortase A has 435 
been hypothesised as a possible target for the prevention of surface protein anchoring 436 
to the peptidoglycan cell wall and adhesin exposure with several distinct sortase 437 
inhibitor classes identified whose aims are to irreversibly modify the thiol active site 438 
of sortase [94][95].     439 
 440 
Future Perspectives 441 
The need to prevent bacterial adherence and eradicate existing established biofilms is 442 
an increasing challenge for an innovative scientific community whose antimicrobial 443 
arsenal is updating at a diminishing rate.  Over the coming years the study of bacterial 444 
biomolecular processes may hold the key to producing effective future antimicrobial 445 
strategies that are targeted specifically to eradicate pathogenic bacteria thus allowing 446 
mutualistic commensal bacteria to thrive in the host environment.  Such an approach 447 
would resolve infection, meet treatment goals and reduce potential systemic side 448 
effects, all without the threat of increased antimicrobial resistance.  In order to 449 
achieve these goals bacterial genotypes must be systematically linked to both 450 
resistance and biomolecular pathways thereby allowing optimum processes to be 451 
targeted.  In order to be of greater success clinically and to reduce the potential for 452 
resistance to develop, such biomolecular strategies will likely be required to be 453 
utilised concurrently with novel biocidal approaches such as the use of antimicrobial 454 
peptides [96] or ionic liquids [97]. 455 
 456 
Executive Summary 457 
Introduction 458 
The ability of bacteria such as Staphylococcus epidermidis and Staphylococcus aureus 459 
to produce exopolysaccharide biofilms allows for increased survival, maturation and 460 
symbiotic relationships to be established at a solid surface environment such as that 461 
present on a medical device.   462 
 463 
Processes involved in Gram-positive biofilm formation: Staphylococcus 464 
epidermidis and Staphylococcus aureus 465 
The biomolecular processes involved in formation of staphylococcal biofilms can be 466 
divided into 5 key areas: 467 
1) Adhesion in staphylococci: Cell surface hydrophobicity and cell surface 468 
adhesins 469 
• The primary or nonspecific adhesion of staphylococci is due mainly to the 470 
cell and cell surface hydrophobicity. 471 
• Capsular polysaccharide-adhesin is responsible for the process of surface 472 
attachment.  Slime associated antigen is linked to accumulation and 473 
biofilm maturation at the surface. 474 
• They are both synthesized from the proteins encoded by the ica operon. 475 
• The secondary attachment of Staphylococcus epidermidis is improved by 476 
the presence of the cell adhesin autolysin E, which binds to plasma 477 
proteins such as vitronectin present in the conditioning layer formed on 478 
implanted biomaterials. 479 
• There are several surface bound proteins in Staphylococcus epidermidis 480 
that are responsible for binding specifically to collagen, vitronectin, 481 
fibronectin and fibrinogen and other proteins present in the extracellular 482 
matrix.   483 
2) The role of teichoic acids 484 
• Cell wall teichoic acids are the highest source of polyanionic charge on 485 
the staphylococcal bacterial cell envelope.   486 
• Increased cationic charge is provided by incorporation of D-alanine 487 
into teichoic acids.  This is a determinant in the successful attachment 488 
of staphylococci to biomaterials. 489 
• The production of teichoic acids is controlled by the dlt gene operon 490 
 491 
3) Accumulation and the ica operon in staphylococci 492 
• The ica gene operon codes for the proteins and enzymes responsible for 493 
polysaccharide intercellular adhesin production.   494 
• The ica gene cluster can be differentiated into the icaA, icaD, icaB and icaC 495 
loci each responsible for relevant pathogenic and virulent factors involved in 496 
polysaccharide intercellular adhesin synthesis. 497 
• The role of the ica gene operon in regulating biofilm formation, adhesion and 498 
virulence has been proven by the introduction of the icaRADBC sequence into 499 
strains of Staphylococcus epidermidis that were previously icaADBC negative 500 
and biofilm negative. 501 
• Regulation of icaR transcription in Staphylococcus epidermidis is controlled 502 
by the alternative sigma factor σB which itself is positively regulated by the 503 
protein RsbU via activation of environmental stresses. 504 
• SarA is an essential element in the synthesis of polysaccharide intercellular 505 
adhesin and biofilm development in Staphylococcus aureus through the 506 
icaADBC operon it is influenced by environmental signals such as ethanol, salt 507 
stress and iron limitation. 508 
• The staphylococcal accessory regulator protein A has been shown to be 509 
positively regulated by σB.  510 
 511 
4) The accumulation associated proteins in staphylococci 512 
• The ica operon itself is not a necessity for biofilm formation. 513 
• Accumulation associated protein has been shown to be involved in the 514 
accumulation of Staphylococcus epidermidis independently of polysaccharide 515 
intercellular adhesin. 516 
• Accumulation associated protein is a cell wall receptor for 517 
polysaccharide intercellular adhesin. 518 
• Proteolytic processing of accumulation associated protein leads to the 519 
removal of the N-terminal domain by proteases resulting in the exposure of N-520 
acetylglucosamine binding domains. 521 
• Protease production is controlled via quorum sensing pathways such as 522 
the agr and sarA in staphylococci. 523 
 524 
5) Quorum sensing in staphylococci:  525 
Two quorum sensing systems exist in staphylococci: 526 
I. The accessory gene regulator system (agr) 527 
• The accessory gene regulator system (agr) consists of two units RNA-II 528 
and RNA-III.  Transcription is dependent on the activation of their 529 
respective P2 and P3 agr promoters. 530 
• RNA-II consists of four genes agrB, agrD, agrC and agrA. 531 
• An autoinductive pathway results in RNA-II and RNA-III (the effector 532 
molecule of the agr system) transcription via the activation of the 533 
promoters P2 and P3 by activated AgrA aided by SarA. 534 
• Staphylococcal accessory regulator gene has been implicated in the agr 535 
quorum sensing system of staphylococci but mediates biofilm formation 536 
via an agr independent pathway.  537 
• The importance of agr to the biofilm process is greatest at the detachment 538 
phase of growth.  539 
• Detachment in staphylococci occurs due to the production of short 540 
amphipathic peptides known as phenol-soluble modulins, e.g. δ-toxin, 541 
encoded by regulatory RNA-III molecule and mediated by the agr 542 
regulatory system. 543 
II. Quorum sensing in staphylococci: the luxS system 544 
• luxS has been linked to preventing the production of polysaccharide 545 
intercellular adhesin in staphylococci via downregulation of icaADBC 546 
• The luxS quorum sensing system is present in both Gram-positive and 547 
Gram-negative bacteria and results in the formation of autoinducing peptide-II 548 
• The synthesis of autoinducer-II occurs in three enzyme enzymatic 549 
steps. 550 
 551 
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